Income statement
USD
Annual
| Metric | 2019 | 2009 | 2008 | 2007 | 2006 |
|---|---|---|---|---|---|
| Revenue | 0 | 1M | 33K | 1M | 129K |
| Gross Profit | 0 | 429K | 28K | 241K | 34K |
| Operating Income | -15K | -1M | -2M | -2M | -1M |
| EBITDA | 160K | -1M | -2M | -2M | -1M |
| Net Income | -16K | -1M | -474K | -2M | -1M |
| EPS (Diluted) | — | — | — | — | — |
Healthcare
Live Price
Offline$0.0001
+0.00% today
1Y Change
+0.00%
Window
Jun 23, 2025 → May 29, 2026
Coverage: 236 bars · Jun 23, 2025 → May 29, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
SES Solar Inc. (SESI) is a Healthcare stock with listed on OTC. The stock last traded around $0.00 and up 0.0% across the available one-year price window (Jun 23, 2025 → May 29, 2026). Baseline metrics include revenue growth of 0.0%, EPS growth of 0.0%, a dividend yield of 0.0%. What stands out right now is revenue 0.0%, EPS 0.0%, free cash flow 0.0% with operating margin 0.0% and ROIC -1419.7%. Stock Foundry combines SESI price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
SESI
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
SESI Max Drawdown
-100.00%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for SESI and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$129.3K
-90.4% YoY
FY Net Income
-$1.2M
+18.7% YoY
Free Cash Flow
-$1.9M
+70.7% YoY
Revenue Growth
+0.0%
EPS Growth
+0.0%
Gross Margin
0.0%
Net Margin
0.0%
Income statement
USD
| Metric | 2019 | 2009 | 2008 | 2007 | 2006 |
|---|---|---|---|---|---|
| Revenue | 0 | 1M | 33K | 1M | 129K |
| Gross Profit | 0 | 429K | 28K | 241K | 34K |
| Operating Income | -15K | -1M | -2M | -2M | -1M |
| EBITDA | 160K | -1M | -2M | -2M | -1M |
| Net Income | -16K | -1M | -474K | -2M | -1M |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
USD
| Metric | 2019 | 2009 | 2008 | 2007 | 2006 |
|---|---|---|---|---|---|
| Cash & Equivalents | 394 | 311K | 766K | 274K | 272K |
| Total Assets | 14K | 23M | 17M | 14M | 7M |
| Total Liabilities | 235K | 21M | 14M | 10M | 2M |
| Shareholder Equity | -221K | 2M | 3M | 4M | 6M |
| Total Debt | 222K | 17M | 12M | 6M | 1M |
| Net Debt | 222K | 17M | 11M | 6M | 933K |
Cash flow positioning
Latest Full Year
Operating Cash Flow
2M
-34.9% YoY
Capital Expenditures
147K
+97.2% YoY
Free Cash Flow
2M
+70.7% YoY
Key ratios
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-1.8%
Debt / Equity
-1.00x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.